MedPath

Effect of Helicobacter pylori eradication on patients suffering rosacea: a clinical trial study

Phase 2
Conditions
Rosacea.
Rosacea
Registration Number
IRCT2015051418946N3
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

confirmed H.pylori infection; Suffering Rosacea.
Exclusion criteria:patients older than 65 and younger than 20; Existanse of any other dermatologic problem; patients refusal to continue study in any stage of study; allergy to clarithromycin, omeprazole; pregnant or breast-feeding; antibiotic therapy within the past 2 months; topical treatment of rosacea in past 3 weeks

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duluth Rosacea Scoring Scale. Timepoint: Before eradication- 60 days after study beginning. Method of measurement: Assessing by dermatologist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath